Literature DB >> 418843

Gold lung.

D W James, W F Whimster, E B Hamilton.   

Abstract

Mesh：

Substances：

Year:  1978        PMID： 418843      PMCID： PMC1605010          DOI： 10.1136/bmj.1.6126.1523-a

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  3 in total

1.  Pulmonary fibrosis associated with hypersensitivity to gold salts.

Authors:  D M Geddes; J Brostoff
Journal:  Br Med J       Date:  1976-06-12

2.  Pulmonary damage associated with sodium aurothiomalate therapy.

Authors:  P W Gould; P L McCormack; D G Palmer
Journal:  J Rheumatol       Date:  1977       Impact factor: 4.666

3.  Diffuse pulmonary injury associated with gold treatment.

Authors:  R H Winterbauer; K R Wilske; R F Wheelis
Journal:  N Engl J Med       Date:  1976-04-22       Impact factor: 91.245
  3 in total
  5 in total

Review 1.  Adverse reactions with oral and parenteral gold preparations.

Authors:  E C Tozman; N L Gottlieb
Journal:  Med Toxicol       Date:  1987 May-Jun

2.  Fatal intrahepatic cholestasis and interstitial lung fibrosis following gold therapy for rheumatoid arthritis.

Authors:  M R Shaban; D N Golding; R G Letcher
Journal:  J R Soc Med       Date:  1984-11       Impact factor: 5.344

3.  Gold-induced lung disease.

Authors:  J Heyd; A Simmeran
Journal:  Postgrad Med J       Date:  1983-06       Impact factor: 2.401

4.  Relationship of gold and penicillamine therapy to diffuse interstitial lung disease.

Authors:  D L Scott; G V Bradby; T J Aitman; G C Zaphiropoulos; C F Hawkins
Journal:  Ann Rheum Dis       Date:  1981-04       Impact factor: 19.103

5.  Pulmonary damage with gold or penicillamine.

Authors:  A Bamji; N Cooke
Journal:  Ann Rheum Dis       Date:  1981-10       Impact factor: 19.103
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.